ClinicalTrials.gg
WithdrawnNCT02052674Updated Jul 24, 2019

Retained Urine Volume and Bacteriuria in Traditional Versus Vented Urine Drainage Systems

A Phase 1 interventional study of Vented urinary drainage system and Non-vented urinary drainage system in Bacteriuria, sponsored by University of Florida. Withdrawn. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2019-07-24.

Sponsored by University of Florida · Phase 1, Interventional, and Prevention

Why this study was withdrawn
Unable to enroll any patients in the study due to other on-going studies.
Phase
Phase 1
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The purpose of this study is to see if there are differences in urine drainage between two types of indwelling bladder catheter systems (Foley catheter) in hospitalized patients. The difference between the two catheters is that one catheter is vented (the study catheter) and the other is a standard non-vented catheter. The vented catheter may drain urine better than a standard non-vented catheter.

If a vented catheter drains the bladder better than a non-vented catheter it may lower the risk of retained urine in the bladder which could help prevent urinary tract infections.

Read the detailed description

During hospitalization, while in the surgical intensive care unit beginning the day after surgery, measurements of the subject's urine drainage system will be taken at daily study visits: retained urine volume, dependent loops, incidence of bacteriuria, and thigh diameter.

02

Conditions studied

  • Bacteriuria

Browse trials for

Keywords

  • Precursor to CAUTI
03

In context

Bacteriuria

51 studies on the registry are indexed under Bacteriuria; 3 are open to participants now.

Browse Bacteriuria studies →

Lead sponsor

University of Florida is the lead sponsor of 1,287 studies on the registry; 199 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for a planned surgery
  • Anticipated indwelling bladder catheter placement for greater than 24 hours
  • Anticipated post-op admission to a surgical ICU

Exclusion criteria

Exclusion Criteria:

  • Unstable renal function as self-reported
  • Anticipated bandaged postoperative suprapubic incisions
  • Anatomical deformity that precludes appropriate suprapubic access for ultrasound bladder scanning
  • Surgical procedure that prevents accurate core body temperature by any means other than by bladder temperature
05

Study design

Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Vented urinary drainage system

    This group will be catheterized with a vented urinary drainage system. Several data sets will be evaluated to compare the two arms of the study: retained urine volume, the difference (ΔH) in meniscus heights in the dependent loops, time necessary for drainage of dependent loops, and incidence of bacteriuria.

    Device: Vented urinary drainage system

  • Active comparator
    Non-vented urinary drainage system

    This group will be catheterized with a non-vented urinary drainage system. Several data sets will be evaluated to compare the two arms of the study: retained urine volume, the difference (ΔH) in meniscus heights in the dependent loops, time necessary for drainage of dependent loops, and incidence of bacteriuria.

    Device: Non-vented urinary drainage system

Interventions

  • DeviceVented urinary drainage system

    This group will be catheterized with a vented urinary drainage system. Several data sets will be evaluated to compare the two arms of the study: retained urine volume, the difference (ΔH) in meniscus heights in the dependent loops, time necessary for drainage of dependent loops, and incidence of bacteriuria.

    Also known as: Covidien vented foley catheter, TopVent, Covidien Dover Precision Premium Drainage bag

  • DeviceNon-vented urinary drainage system

    This group will be catheterized with a non-vented urinary drainage system. Several data sets will be evaluated to compare the two arms of the study: retained urine volume, the difference (ΔH) in meniscus heights in the dependent loops, time necessary for drainage of dependent loops, and incidence of bacteriuria.

    Also known as: Bard urine drainage system, Conventional catheter, Bard Silver-Coated

06

What researchers measure

Primary outcomes

  1. Bacteriuria

    Evidence of bacteriuria, a potential precursor to Catheter Associated Urinary Tract Infection (CAUTI), will be used to study the potential effect of the vented urinary drainage system intervention on CAUTI.

    Time frame: 7 days

Secondary outcomes

  1. Retained Urine

    One potential source for the risk of developing a Urinary Tract Infection (UTI) is related to residual urine volume in the bladder

    Time frame: 7 days

  2. Presence of biofilms in catheter materials

    A key contributor to bacteriuria is formation of biofilms in the catheter and catheter tubing.

    Time frame: 7 days

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2015, a primary completion of Apr 2015 and a completion of Apr 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2014
First posted
Feb 3, 2014
Start
Mar 2015
Primary completionActual
Apr 2015
CompletionActual
Apr 2015
Last update
Jul 24, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02052674
Responsible party
Sponsor
First posted
Feb 3, 2014
Start date
Mar 2015
Primary completion
Apr 2015
Completion
Apr 2015
Last update
Jul 24, 2019

Study contacts

William B. Smith, MD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion